THE EFFECT OF EXOGENOUS GLUCAGON LIKE PEPTIDE-1 (GLP-1) ON SMALL INTESTINAL GLUCOSE MISORPTION UN THE CRITICALLY ILL

被引：0
|
作者：
Cousins, C. E. [1 ]
Miller, A. [1 ]
Plummer, M. P. [1 ,2 ,3 ]
Deane, A. M. [1 ,2 ,3 ]
Horowitz, M. [4 ]
Chapman, M. J. [1 ,2 ,3 ]
机构：
[1] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Adelaide, SA, Australia
[3] Ctr Clin Res Excellence Nutr Physiol Intervent &, Adelaide, SA, Australia
[4] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
来源：
INTENSIVE CARE MEDICINE | 2014年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0519
引用
收藏
页码：S147 / S148
页数：2
相关论文
共 50 条
  • [31] STRUCTURE OF HUMAN GLP-1(GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    DIABETOLOGIA, 1992, 35 : A109 - A109
  • [32] Glucagon-like peptide 1 (GLP-1)
    Mueller, T. D.
    Finan, B.
    Bloom, S. R.
    D'Alessio, D.
    Drucker, D. J.
    Flatt, P. R.
    Fritsche, A.
    Gribble, F.
    Grill, H. J.
    Habener, J. F.
    Holst, J. J.
    Langhans, W.
    Meier, J. J.
    Nauck, M. A.
    Perez-Tilve, D.
    Pocai, A.
    Reimann, F.
    Sandoval, D. A.
    Schwartz, T. W.
    Seeley, R. J.
    Stemmer, K.
    Tang-Christensen, M.
    Woods, S. C.
    DiMarchi, R. D.
    Tschoep, M. H.
    MOLECULAR METABOLISM, 2019, 30 : 72 - 130
  • [33] Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo
    Wu, Ye-Lin
    Huang, Jing
    Xu, Jin
    Liu, Jian
    Feng, Zhen
    Wang, Yang
    Lai, Yuping
    Wu, Zi-Rong
    REGULATORY PEPTIDES, 2010, 164 (2-3) : 83 - 89
  • [34] Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor
    Helmstaedter, Johanna
    Keppeler, Karin
    Kuester, Leonie
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 659 - 676
  • [35] Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1)
    Yamato, E
    Ikegami, H
    Takekawa, K
    Fujisawa, T
    Nakagawa, Y
    Hamada, Y
    Ueda, H
    Ogihara, T
    HORMONE AND METABOLIC RESEARCH, 1997, 29 (02) : 56 - 59
  • [36] Effects of glucagon and glucagon-like peptide-1 (GLP-1) on glycemic status and glucose production in the isletectomized diabetic goby.
    Haigwood, JT
    Perez, M
    Kelley, KM
    AMERICAN ZOOLOGIST, 2000, 40 (06): : 1038 - 1039
  • [37] Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9-36 Amide at the GLP-1 Receptor
    Li, Naichang
    Lu, Jing
    Willars, Gary B.
    PLOS ONE, 2012, 7 (10):
  • [38] Exogenous Glucagon-Like Peptide-1 for Hyperglycemia in Critically III Patients
    Pinelli, Nicole R.
    Jones, Mathew C.
    Monday, Lea M.
    Smith, Zachary
    Rhoney, Denise H.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (01) : 124 - 129
  • [39] Preserved Inhibitory Effect of Glucagon-Like Peptide-1 (GLP-1) on Glucagon Secretion in Type 2 Diabetes Mellitus
    Hare, Kristine J.
    Knop, Filip K.
    Asmar, Meena
    Larsen, Steen
    Madsbad, Sten
    Holst, Jens J.
    Vilsboll, Tina
    DIABETES, 2009, 58 : A372 - A372
  • [40] The Effect of Exogenous GIP in Combination With GLP-1 on Glycaemia in Critically Ill Patients
    Lee, Michael
    Umapathysivam, Mahesh
    Deane, Adam M.
    Chapman, Marianne
    Sundararajan, Krishnaswamy
    Fraser, Jonathan
    Cousins, Caroline
    Annink, Christopher
    Horowitz, Michael
    Meier, Juris J.
    Rayner, Christopher K.
    DIABETES, 2013, 62 : A259 - A259
12345